ALPS Medical Breakthroughs ETF Rating $37.16 +0.27 (+0.73%) (As of 11/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.91Holdings in SBIO have an aggregate rating of Moderate Buy based on 472 analyst ratings issued in the past year covering 50 companies (82.0% of the portfolio).SBIO Aggregate Price Target$37.16High Prediction$37.16Average Prediction$37.16Low Prediction$37.16Holdings in SBIO have an aggregate price target of $37.16 and a range of $37.16 to $37.16 covering 50 companies (82.0% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy28 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.46%CORTCorcept Therapeutics$56.09+3.3%4.6651 of 5 stars3.00$65.25 16.3%53.33%RNAAvidity Biosciences$43.65+0.9%2.3883 of 5 stars3.00$63.22 44.8%9Insider TradeAnalyst Revision3.28%KRYSKrystal Biotech$178.10+0.1%4.8348 of 5 stars3.00$202.29 13.6%8Positive News3.05%ACLXArcellx$87.22-0.4%2.9241 of 5 stars3.07$103.08 18.2%14Short Interest ↓2.96%ALKSAlkermes$27.91+1.6%4.7788 of 5 stars2.58$35.42 26.9%12Positive News2.87%CRNXCrinetics Pharmaceuticals$56.07+1.6%3.5524 of 5 stars2.91$70.18 25.2%11Analyst Revision2.84%IMVTImmunovant$26.17+3.8%1.5467 of 5 stars3.00$48.10 83.8%112.51%DNLIDenali Therapeutics$24.42+0.3%4.4648 of 5 stars2.73$38.90 59.3%112.27%MRUSMerus$42.93-1.3%1.9713 of 5 stars3.15$86.70 102.0%13Analyst Forecast2.05%XENEXenon Pharmaceuticals$39.34+1.3%3.4913 of 5 stars3.08$57.45 46.0%12Analyst Revision2.04%FOLDAmicus Therapeutics$9.59+0.7%4.6577 of 5 stars2.89$17.63 83.8%92.02%EWTXEdgewise Therapeutics$31.95+1.4%1.7269 of 5 stars3.00$38.40 20.2%52.01%PTCTPTC Therapeutics$41.96+6.6%2.5538 of 5 stars2.33$42.00 0.1%15Analyst Downgrade1.88%VRNAVerona Pharma$38.85+2.0%2.5968 of 5 stars3.00$43.83 12.8%6Positive News1.81%ZLABZai Lab$26.23+0.3%2.9574 of 5 stars3.00$52.50 100.2%4Analyst Revision1.80%MLTXMoonLake Immunotherapeutics$49.82+1.0%3.2708 of 5 stars2.90$79.00 58.6%101.77%AGIOAgios Pharmaceuticals$54.62+0.4%3.3113 of 5 stars2.50$52.33 -4.2%81.70%VERAVera Therapeutics$45.75-0.3%3.3108 of 5 stars3.11$57.88 26.5%91.69%PTGXProtagonist Therapeutics$40.65+5.2%3.0192 of 5 stars3.14$53.57 31.8%7Analyst ForecastNews Coverage1.67%CGONCG Oncology$32.24-1.7%3.1626 of 5 stars3.11$63.88 98.1%9Short Interest ↓Analyst Revision1.67%APGEApogee Therapeutics$45.04-3.2%2.241 of 5 stars3.00$78.50 74.3%61.61%ACADACADIA Pharmaceuticals$16.27+0.4%3.9106 of 5 stars2.65$25.56 57.1%17Insider TradeAnalyst Revision1.58%IDYAIDEAYA Biosciences$25.54-1.2%4.1381 of 5 stars2.94$53.67 110.1%16Analyst Forecast1.56%GERNGeron$3.99+5.3%3.492 of 5 stars3.00$7.05 76.7%111.50%AKROAkero Therapeutics$30.64-1.3%4.047 of 5 stars2.88$46.83 52.9%8Analyst ForecastInsider Trade1.48%KROSKeros Therapeutics$54.14+1.0%3.4913 of 5 stars3.00$88.89 64.2%121.43%VCELVericel$57.26+2.6%1.0623 of 5 stars3.00$58.14 1.5%7Analyst Forecast1.33%SLNOSoleno Therapeutics$54.83+5.9%3.9917 of 5 stars3.14$74.83 36.5%71.27%LBPHLongboard Pharmaceuticals$59.77-0.1%1.4763 of 5 stars2.44$59.56 -0.4%91.24%MNKDMannKind$6.88+0.3%3.7142 of 5 stars3.14$8.67 26.0%7Insider Trade1.22%MIRMMirum Pharmaceuticals$43.69+3.8%4.2959 of 5 stars3.17$57.73 32.1%12Analyst Revision1.21%NAMSNewAmsterdam Pharma$20.01-15.5%2.936 of 5 stars3.00$33.80 68.9%7Insider TradeNews CoverageGap DownHigh Trading Volume1.20%NMRANeumora Therapeutics$9.79-0.7%1.5908 of 5 stars2.71$21.67 121.3%71.20%ARVNArvinas$22.69+4.9%3.0807 of 5 stars2.93$61.08 169.2%14Analyst ForecastShort Interest ↓1.19%IRONDisc Medicine$62.55+5.0%3.1622 of 5 stars3.10$85.80 37.2%10Insider TradeAnalyst Revision1.13%SNDXSyndax Pharmaceuticals$15.95+1.1%3.9967 of 5 stars2.91$37.18 133.1%11Analyst ForecastAnalyst Revision1.12%CLDXCelldex Therapeutics$26.40+5.7%2.8776 of 5 stars2.89$62.25 135.8%9Analyst ForecastNews Coverage1.09%TARSTarsus Pharmaceuticals$46.58-0.7%1.8691 of 5 stars3.00$54.20 16.4%7Analyst Revision1.08%GLPGGalapagos$25.64-3.9%1.2816 of 5 stars1.71$30.75 19.9%7Analyst DowngradeShort Interest ↓Gap DownHigh Trading Volume1.03%IMCRImmunocore$32.42-0.4%2.9958 of 5 stars2.62$69.18 113.4%13Positive News0.98%BCRXBioCryst Pharmaceuticals$7.30+1.2%4.2329 of 5 stars2.80$15.60 113.7%5Short Interest ↓0.98%NTLAIntellia Therapeutics$13.12-7.1%4.5239 of 5 stars2.72$54.94 318.7%18Analyst Forecast0.91%VRDNViridian Therapeutics$19.79-2.2%2.347 of 5 stars2.80$36.33 83.6%10Analyst Revision0.89%SPRYARS Pharmaceuticals$13.55-1.7%2.734 of 5 stars3.33$24.00 77.1%6Analyst Revision0.87%XNCRXencor$23.72+0.4%3.5459 of 5 stars3.00$35.75 50.7%80.86%RCUSArcus Biosciences$14.62+0.8%2.677 of 5 stars3.00$34.00 132.6%90.86%DAWNDay One Biopharmaceuticals$13.62+0.7%1.9859 of 5 stars3.00$35.71 162.2%9Positive News0.85%PHVSPharvaris$20.500.0%1.6408 of 5 stars2.60$33.60 63.9%50.84%KURAKura Oncology$15.91-0.3%4.0784 of 5 stars3.00$28.83 81.2%8Analyst Forecast0.77%PRAXPraxis Precision Medicines$73.68+1.3%1.754 of 5 stars2.89$146.33 98.6%9 This page (NYSEARCA:SBIO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBIO Stock Alerts